Why a Z-Code Identifier Doesn’t Equal MolDX Reimbursement
By: Tami Shaw, Client Manager, RCM Solutions In the Spring of 2022, states participating in a Medicare MAC utilizing the MolDX program were subject to changes requiring registration for Infectious Disease testing if the panel in question is a lab developed test (LDT)....
VALID Act Excluded from Omnibus Package, Payment Cuts Delayed
In a win for laboratory innovation, the VALID Act, which would have created a new risk-based framework for regulating lab developed tests (LDTs), was excluded from the year-end omnibus spending package recently finalized by Congress, meaning the legislation...
What’s Standard for Medical Lab Billing Contracts?
Entering into an agreement for medical billing services is an important process for any clinical lab or pathology group who does not have this service provided by a hospital or other partner. But what metrics and capabilities should a medical group or lab be looking...
2023 Medicare PFS: See Impact to Labs and Pathology
The 2023 Medicare Physician Fee Schedule Final Rule was released by CMS late Thursday, Nov 3. After two consecutive years of Congress delaying a number of anticipated reimbursement cuts due to the impact of the COVID pandemic, it now appears these previously planned...